AI Insight: Axon Enterprise trades significantly above its weighted fair value of $243.01, indicating potential overvaluation with a 60.1% downside implied by valuation models. Conflicting signals arise from high analyst target valuations versus deeply negative DCF results, stressing profitability and efficiency weaknesses despite strong growth and liquidity. Monte Carlo analysis shows minimal near-term downside risk, reflecting market optimism or possible momentum effects.